Popularly known as the tea of santo daime, ayahuasca is a beverage produced from the combination of the vine mariri with other herbs, the main ones being the p. viridis and d. cabrerana, also called chagropanga.
Present in mankind for several millennia, the drink is often used in some religious rituals by various social groups, mainly indigenous tribes native to the Amazon, and this is also part of their traditional medicine.
Their intake results in an effect enteógeno, where the individual enters a state of trance and have an experience that changes the functioning of your consciousness, greatly increases your perception and allows you to access the various levels of the subconscious. Many people compare the experience with a deep meditation.
There is a large scientific interest because of on the properties present in the drink and its ingredients for medicinal use , as there are several reports that thanks to them, people healed of psychological problems, ranging from dependence of any substance, until the depression.
In a recent survey done in partnership between the Institute D’Or Research and Education (Idor) and the Institute of Biomedical Sciences of the Federal University of Rio de Janeiro (ICB-UFRJ), it was found that the vine mariri is rich in a substance called harmine, and that she is able to assist in the regeneration of neurons. This discovery may be of great importance to the development of treatments for neurological diseases, such as Alzheimer’s, which so far, has no cure.
In previous studies, it has been proved that the plant possesses properties that result in effects that combat the anxiety and depression.
During the experiments, the researchers placed parents in the neural, which are cells capable of transforming structures neural human, exposed to harmine. After only four days, the compound had increased by 71% the amount of cells.
The surprising result prompted the team of researchers trying to figure out how the substance acts on the parents to neural.
“We use a variety of tools, biochemical and concluded that it inhibits an enzyme called DYRK1A. And the interesting thing is that this enzyme is highly activated in the Alzheimer and Down syndrome”, he told Stevens Rehens, one of the researchers of the Idor. “We need to do more studies in this direction. We have a first evidence. It is the first brick of a work that seeks to highlight substances that are often banned, but have a therapeutic potential that needs to be studied” he said Rehens.